OTC Markets OTCPK - Delayed Quote USD
Awakn Life Sciences Corp. (AWKNF)
0.0650
0.0000
(0.00%)
As of April 21 at 4:00:00 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.26M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Held, Jonathan James Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 0.42 per share. | Indirect | 10,400 | Sep 15, 2022 |
| Nutt (David John) Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 0.42 per share. | Indirect | 25,080 | Sep 14, 2022 |
| Held, Jonathan James Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.49 per share. | Indirect | 974 | Jun 22, 2022 |
| Held, Jonathan James Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.49 per share. | Indirect | 4,148 | Jun 21, 2022 |
| Held, Jonathan James Senior Officer of Issuer | Acquisition or disposition in the public market at price 0.42 per share. | Indirect | 4,220 | Jun 17, 2022 |
| Scorsis (George) Director of Issuer | Acquisition or disposition in the public market at price 0.97 per share. | Direct | 487 | May 24, 2022 |
| Scorsis (George) Director of Issuer | Acquisition or disposition in the public market at price 0.98 per share. | Direct | 589 | May 24, 2022 |
| Scorsis (George) Director of Issuer | Acquisition or disposition in the public market at price 1.22 per share. | Direct | 489 | Apr 20, 2022 |
| Scorsis (George) Director of Issuer | Acquisition or disposition in the public market at price 1.21 per share. | Direct | 606 | Apr 18, 2022 |
| Scorsis (George) Director of Issuer | Acquisition or disposition in the public market at price 1.21 per share. | Direct | 485 | Apr 18, 2022 |
| Held, Jonathan James Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 1.27 per share. | Direct | 19,827 | Mar 21, 2022 |
| Scorsis (George) Director of Issuer | Acquisition or disposition under a prospectus exemption at price 1.27 per share. | Direct | 19,827 | Mar 21, 2022 |
| Papastergiou (John) Director of Issuer | Acquisition or disposition under a prospectus exemption at price 1.27 per share. | Indirect | 39,718 | Mar 21, 2022 |
| Nutt (David John) Senior Officer of Issuer | Acquisition or disposition under a prospectus exemption at price 1.27 per share. | Indirect | 38,447 | Mar 21, 2022 |
| Orbimed Capital, L.L.C. 10% Security Holder of Issuer | Acquisition or disposition under a prospectus exemption at price 1.27 per share. | Indirect | 397,187 | Mar 21, 2022 |
| Held, Jonathan James Senior Officer of Issuer | Acquisition or disposition in the public market at price 1.69 per share. | Indirect | 1,690 | Jan 24, 2022 |
| Scorsis (George) Director of Issuer | Acquisition or disposition in the public market at price 1.88 per share. | Direct | 3,984 | Jan 21, 2022 |
| Held, Jonathan James Senior Officer of Issuer | Acquisition or disposition in the public market at price 2.05 per share. | Indirect | 2,054 | Jan 19, 2022 |
| Held, Jonathan James Senior Officer of Issuer | Acquisition or disposition in the public market at price 2.01 per share. | Indirect | 4,229 | Jan 18, 2022 |
| Held, Jonathan James Senior Officer of Issuer | Acquisition or disposition in the public market at price 2.12 per share. | Indirect | 12,702 | Jan 17, 2022 |
| Carter (Paul Rutherford) Director of Issuer | -- | Direct | -- | Dec 14, 2021 |
Related Tickers
OCTHF Oxford Cannabinoid Technologies Holdings Plc
0.0028
0.00%
RDTCF Rapid Dose Therapeutics Corp.
0.1393
0.00%
SRBCF Sirona Biochem Corp.
0.0186
0.00%
FNAM Evolutionary Genomics, Inc.
0.0002
0.00%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
BXPHF Botanix Pharmaceuticals Limited
0.2300
0.00%
HAVLF HAVN Life Sciences Inc.
0.0010
0.00%
ENBI.CN Entheon Biomedical Corp.
0.1150
0.00%
MSCLF Satellos Bioscience Inc.
0.4600
-0.56%
FAMDF Futura Medical plc
0.0900
0.00%